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Abstract
Aims To investigate the impact of a 2.5-year diabetes self-management education and support intervention on
healthcare use and to examine factors associated with patterns of healthcare use.
Methods We recruited 60 African-American adults with Type 2 diabetes who completed a 2.5-year empower-
ment-based diabetes self-management education and support intervention. Primary healthcare use outcomes included
acute care visits, non-acute care visits and days lost to disability. Acute care was a composite score calculated from the
frequency of urgent care visits, emergency department visits and hospitalizations. Non-acute care measured the
frequency of scheduled outpatient visits. To examine change in patterns of healthcare use, we compared the frequency of
healthcare visits over the 6-month period preceding the intervention with that in the last 6 months of the intervention.
Results No significant changes in patterns of healthcare use were found for acute care, non-acute care or days lost to
disability. Multiple regression models found higher levels of depression (P = 0.001) to be associated with a greater
number of non-acute healthcare visits, and found longer duration of diabetes (P = 0.019) and lower levels of diastolic
blood pressure (P = 0.025) to be associated with fewer days lost to disability.
Conclusions Participation in a long-term diabetes self-management education and support intervention had no impact
on healthcare use in our sample of African-American subjects.
Diabet. Med. 31, 472–476 (2014)
Introduction
Not only are racial disparities evident in diabetes-related
morbidity and mortality, but also in use of healthcare
services. Compared with their white counterparts, Afri-
can-American people with diabetes are more likely to make
emergency department visits [1,2], seek emergency care
inappropriately [3] and have preventable hospitalizations
[3–5], and are less likely to make ambulatory care visits [6],
have a usual source of care [1] and order prescription refills
[6]. African-American people also report higher rates of
diabetes-related work disability [7].
While numerous systematic reviews andmeta-analyses have
found diabetes self-management interventions to be associated
with improved clinical, behavioural and psychosocial out-
comes [8–15], only a small number of investigations targeting
the African-American population have examined healthcare
use as an endpoint of interest [16–19]. These studies have
found self-management interventions to be associated with
fewer emergency department visits [16–19], fewer and shorter
hospitalizations [16,18,19] and fewer missed workdays [19].
Only one has examined the impact of a long-term (vs
short-term) diabetes self-management intervention on health-
care use outcomes, with patients recruited through a managed
care organization [9]. To our knowledge, there are no studies
that address this same question with African-American
patients recruited directly through the community.
For this reason, the primary objective of the present study
was to compare healthcare use outcomes in the 6-month
period preceding the 2.5-year diabetes self-management
education and support intervention with those in the last
6 months of the intervention. The secondary objective was to
identify any demographic and clinical predictors of patterns
of healthcare use.Correspondence to: Tricia S. Tang. E-mail: tricia.tang@vch.ca
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The present study was approved by the institutional review
boards at the University of Michigan and the University of
British Columbia and is part of a larger study examining the
health impact of the Lifelong Management programme (i.e. a
2.5-year-long diabetes self-management education and sup-
port intervention) on clinical, self-care and psychosocial
outcomes [20]. Briefly, the present study was a single-cohort,
time-series design that prospectively followed 60 Afri-
can-American participants with Type 2 diabetes (who
completed the intervention) in Ypsilanti, MI, USA from
2005 to 2009.
Participants were recruited (2005–2006) from the com-
munity via newspaper advertisements, community flyers,
health centres and invited presentations at churches with a
large African-American membership. To be eligible for
participation, subjects had to be ≥ 40 years of age, have a
diagnosis of Type 2 diabetes for at least 1 year, have received
structured diabetes education in the past 3 years, and be
under the care of a physician. Individuals who were unable to
attend the orientation or group sessions because of physical
limitations (they were home-bound) or other comorbid
conditions were excluded from participation.
Lifelong Management programme
Lifelong Management is a 2.5-year intervention that started
with a 6-month low-intensity self-management education
component, where participants and their self-identified
diabetes care provider received clinical feedback and partic-
ipants also received weekly educational newsletters [14]. The
clinical feedback was sent in a diabetes risk profile and
included results for HbA1c, LDL, HDL, total cholesterol,
systolic and diastolic blood pressure and BMI. Participants’
laboratory values were highlighted if they fell outside the
target range. Recommendations (e.g. exercising, eating less
fat, eating more fibre) on how to reach the target range were
also provided. The weekly educational newsletters addressed
the nine core diabetes education topics (e.g. diabetes disease
process, healthy eating, chronic complications) defined by the
National Standards of Diabetes Self-Management Education
[21].
The next 24 months continued with a high-intensity
diabetes self-management support component consisting of
weekly group-based 75 minute support sessions (75-min in
length) co-facilitated by a certified diabetes educator and a
clinical psychologist. The support component was designed
based on patient empowerment principles which emphasize
that: (1) patients (not providers) make the majority of daily
self-management decisions; (2) behaviour change is more
likely to be initiated and sustained if self-management goals
are patient-selected (vs provider-selected); and (3) providers
serve as consultants to patients who make the ultimate
informed decisions [22]. Rather than being guided by a
rigidly structured and provider-centered curriculum, there-
fore, discussion topics were driven entirely by patients’
questions, concerns and priorities.
While the content of discussions was patient-directed, the
sessions followed a general, yet fluid process where facilita-
tors encouraged participants to: (1) discuss recent self-man-
agement experiences; (2) share thoughts and feelings
associated with these experiences; (3) ask self-management
questions; (4) engage in group-based problem-solving; and
(5) set behavioural goals and develop action plans. For
example, a group session might start with a participant
telling the group that he/she woke with an unusually high
blood sugar. The facilitators would then encourage the
participant to share his/her feelings about this situation.
Participants would be invited to ask relevant self-manage-
ment questions such as how to treat high or low blood sugar.
After the participant-initiated discussion on short-term
complications, the facilitators would encourage the group
to generate solutions (if appropriate) to the participant’s
problem. Finally, at the end of the session, facilitators would
assist participants with identifying a self-management goal
for the week. To accommodate differing schedules, sessions
were offered in the morning and afternoon. Participants were
encouraged to attend sessions as frequently as they felt they
needed or were able to given their life circumstances.
Measures
Healthcare use was measured with self-report questionnaires
administered via telephone interview every 3 months. It is
important to note that healthcare use for the 6 months
preceding the 2.5-year intervention were assessed retrospec-
tively in the baseline questionnaire. We categorized health-
care use into three outcomes: acute care, non-acute care and
days lost to disability. Because of the low frequency of
What’s new?
• This is one of only two studies examining healthcare use
as anoutcome of a long-term self-management education
and a support intervention targeting African-American
adults with Type 2 diabetes.
• Participation in a 2.5-year diabetes self-management
education and support intervention has no impact on
acute care visits, non-acute care visits or days lost to
disability.
• Depressive symptomatology is a significant predictor of
non-acute healthcare use.
• Duration of diabetes and diastolic blood pressure are
significant predictors of days lost to diabetes-related
disability.
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hospitalizations and/or emergency department visits over
the 6-month periods being compared, acute care was
calculated as a composite score of urgent care visits,
emergency visits and hospitalizations and assessed using
the following questions: ‘During the past 3 months, how
many times have you had urgent care visit(s)’; ‘During the
past 3 months, how many times have you had emergency
room visit(s)?’; ‘During the past 3 months, were you a
patient in a hospital overnight?’; and ‘If yes, how many
times in the past 3 months did you stay in the hospital
overnight?’
Non-acute care consisted of scheduled outpatient appoint-
ments and was assessed using the following question: ‘During
the past 3 months, how many times have you had regularly
scheduled outpatient visits?’ Days lost to disability was
reported within a 4-week window and was assessed with the
following question: ‘During the past 4 weeks, how many
days have you lost from school, work or household activities
due to illness or injury?’
Demographic variables were self-reported and included
age, years since diagnosis, gender, marital status, education,
household income, employment and insurance coverage.
Clinical variables included HbA1c, LDL, HDL, total choles-
terol, blood pressure (systolic and diastolic), BMI and
weight. HbA1c and lipid panel were obtained via venous
puncture. The HbA1c method used over the course of the
study was the Tosoh G7 analyser (normal range: 3.8 – 6.4%;
Tosoh Bioscience Inc., San Francisco, CA, USA) and is
certified by the National Glycohemoglobin Standardization
Programme; therefore, the results are comparable with those
from methods used in the Diabetes Control and Complica-
tions Trial. In addition, the laboratory used for the study
remained the same over the study period. Blood pressure was
measured using an Omron automatic blood pressure monitor
(Commonhealthcare, Lake Forest, IL, USA). Depression,
diabetes empowerment, and diabetes-related distress were
also self-reported and assessed using the Patient Health
Questionnaire-9 [23]. Diabetes Empowerment Scale-short
form [24], and Diabetes Distress Scale [25], respectively.
Statistical analyses
Due to the skewed distribution of the variables, Wilcoxon
signed-rank tests were used to compare healthcare use during
the 6 months preceding the 2.5-year intervention with
healthcare use in the last 6 months (i.e. the last 6 months
of the 2.5-year intervention) of the Lifelong Management
programme. Parametric and non-parametric correlational
analyses were used to identify likely baseline demographic,
clinical and psychosocial predictors in determining health-
care use. Variables that were significantly associated with
patterns of healthcare use were then entered into three
separate multiple regression analyses for acute care use,
non-acute care use and days lost to disability.
Results
Characteristics of sample at baseline
At baseline, 89 participants were enrolled into the study
and 60 participants completed the 2.5-year intervention
yielding an attrition rate of 33%. The mean age of the
sample (n = 60) was 62 years, the mean time since
diagnosis was 12 years, 70% of the sample were women,
80% were retired,70% had post-high school education,
and 36% reported a household income of ≤ $20,000. At
baseline, the mean HbA1c concentration was 64 mmol/mol
(8.0%), the mean (SD) LDL concentration was 2.56 (0.86)
mmol/L, the mean (SD) HDL concentration was 1.34 (7.3)
mmol/L, the mean (SD) systolic blood pressure was 136.9
(17.5) mm/Hg, the mean diastolic blood pressure was 80.0
(10.6) mm/Hg, the mean (SD) BMI was 34.5 (7.3) kg/m2;
and the mean (SD) weight was 94.0 (20.0) kgs. In all, 27%
of the subjects (n = 16) reported using insulin with a mean
duration of insulin use of 12.5 years, and 77% (n = 46)
reported taking oral agents with 13% (n = 6) of those
participants also among the insulin users. A total of 75%
(n = 45) of the subjects reported taking cholesterol med-
ication and 85% (n = 51) reported taking blood pressure
medication.
Healthcare use
No significant differences in acute care use, non-acute care
use or days lost to disability were found between the
6 months preceding the intervention and the last 6 months
of the intervention, although the difference in non-acute care
use approached significance (Table 1).
Predictors of healthcare use
To identify which predictors to include in the regression
models, we first conducted bivariate correlations between
potential predictors (clinical, demographic, psychosocial
variables) and healthcare use outcomes (acute care, non-
acute care, days lost to disability). Variables found to be
significantly associated with healthcare use outcomes would
then be entered as predictors into separate regression models
for acute care, non-acute care and days lost to disability.
No clinical, demographic or psychosocial variables were
associated with acute care use. A significant regression model
emerged (adjusted R2 = 0.250) for non-acute care (Table 2).
The only significant predictor for non-acute care was
depression. Participants with higher levels of depression
reported a greater number of non-acute healthcare visits. A
significant model emerged (adjusted R2 = 0.212) for days lost
to disability. Significant predictors included the duration of
diabetes and diastolic blood pressure (Table 2). Participants
who had been diagnosed with diabetes for a longer duration
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and had lower diastolic blood pressure reported fewer days
lost to disability.
Discussion
Although the Lifelong Management programme was associ-
ated with initial and sustained clinical and self-care improve-
ments [20], the present study shows that this intervention
had no impact on patterns of healthcare use. These results
contradict the study by Gary et al. [16], which found a
significant decline in emergency room visits after a 2-year
nurse case manager and community health worker team
intervention (conducted within a managed care organization
system) compared with a control group. Unlike the Lifelong
Management intervention, that study involved nurse case
managers who provided one-on-one clinical support and
community health workers who made home visits over a
period of 2 years. It is likely that an intervention deployed
within a healthcare system and designed with a peer support
component offers greater treatment intensity and thereby
exerts a greater influence on healthcare use outcomes;
however, in the present study, no significant associations
were found between attendance rate (i.e. treatment intensity)
and healthcare use outcomes.
While the present study identified depression as a signif-
icant predictor of non-acute care use, Husaini et al. [26]
found depressive symptoms to be correlated with a threefold
increase in acute care use (emergency room visits and
inpatient hospitalizations) among African-American patients
with Type 2 diabetes. Although these findings are inconsis-
tent, both studies support the larger body of research
highlighting the negative impact of diabetes and depression
on health and healthcare-related outcomes, including treat-
ment adherence [27], cost [28] and mortality [29].
Several limitations of the present study should be noted.
Because this community-based study recruited patients from
different healthcare systems, rather than using administrative
data we relied on self-report data, which is subject to recall
bias and inaccuracy. To reduce potential inaccuracies, we
asked participants to report healthcare use behaviour over a
period of 6 months rather than over an entire year. It is
possible that 6 months does not provide enough time to
capture differences in behaviours such as emergency visits,
hospitalizations and scheduled outpatient appointments. In
fact, our results found non-acute care visits to increase in the
last 6 months of the intervention; however, this difference
only approached significance (P = 0.051). Possibly, with a
larger sample size and a longer evaluation interval, we would
be able to detect significant differences it they existed.
Healthcare use is an important outcome to evaluate as it
has clear implications for the cost-effectiveness of interven-
tions. To identify the specific intervention components or
mechanisms that influence patterns of use, subsequent studies
targeting the African-American population need to include
measures of healthcare use as a requisite endpoint.
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Last 6 months of intervention
Mean (SD) P
Number of non-acute care visits 3.02 (2.66) 3.88 (2.88) 0.051*
Number of acute care visits 0.93 (2.69) 0.98 (2.65) 0.833
Number of urgent care visits 0.17 (0.53) 0.03 (0.18) 0.070
Number of emergency room visits 0.48 (1.30) 0.47 (1.39) 0.811
Number of hospitalizations 0.28 (1.12) 0.48 (1.31) 0.223
Number of days lost to disability in past month 1.64 (5.181) 1.35 (3.26) 0.550
*The difference in non-acute care visits approached significance.
Table 2 Predictors of nonacute care use and days lost to disability
Outcome variable Predictor variable Mean SD b P
Nonacute care utilization Age 63.2 9.74 0.002 0.988
Education (categorical) – – 0.0288 to 0.107 0.290 to 0.982
Depression score* 5.64 5.54 0.463 0.001
Days lost to disability Years since diagnosis at baseline 12.1 11.7 0.317 0.019
Diastolic blood pressure 80.0 10.9 0.301 0.025
Depression score 5.30 5.33 0.208 0.116
Diabetes empowerment score 3.92 0.85 0.044 0.737
*Higher scores indicate greater symptom severity.
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